Astrana Health (NASDAQ:ASTH) Issues FY24 Earnings Guidance

Astrana Health (NASDAQ:ASTH) updated its FY24 earnings guidance on Thursday. The company provided earnings per share guidance of $1.06-1.19 for the period, compared to the consensus earnings per share estimate of $1.23. The company issued revenue guidance of $1.95-2.03 billion, compared to the consensus revenue estimate of $1.84 billion.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on ASTH shares. TD Cowen began coverage on shares of Astrana Health in a report on Monday, October 14th. They issued a “buy” rating and a $66.00 target price on the stock. Truist Financial lifted their price objective on shares of Astrana Health from $50.00 to $59.00 and gave the company a “buy” rating in a research note on Friday, August 9th. Robert W. Baird boosted their price target on Astrana Health from $54.00 to $67.00 and gave the company an “outperform” rating in a research report on Thursday, August 15th. BTIG Research increased their price objective on Astrana Health from $60.00 to $70.00 and gave the stock a “buy” rating in a research report on Thursday, October 3rd. Finally, KeyCorp initiated coverage on Astrana Health in a report on Friday, October 11th. They issued a “sector weight” rating on the stock. One investment analyst has rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, Astrana Health has a consensus rating of “Buy” and an average price target of $62.00.

Astrana Health Stock Performance

NASDAQ ASTH traded down $0.41 during trading hours on Thursday, hitting $59.08. 279,308 shares of the stock were exchanged, compared to its average volume of 197,387. The company has a quick ratio of 1.84, a current ratio of 1.84 and a debt-to-equity ratio of 0.62. The company has a market cap of $2.90 billion, a price-to-earnings ratio of 41.31, a price-to-earnings-growth ratio of 2.08 and a beta of 1.24. Astrana Health has a 12-month low of $29.63 and a 12-month high of $63.20. The stock has a 50-day moving average of $55.30 and a 200 day moving average of $47.32.

Astrana Health (NASDAQ:ASTH) last announced its quarterly earnings data on Wednesday, August 7th. The company reported $0.40 earnings per share for the quarter, topping analysts’ consensus estimates of $0.39 by $0.01. The firm had revenue of $486.30 million for the quarter, compared to analyst estimates of $440.68 million. Astrana Health had a return on equity of 10.71% and a net margin of 4.30%. Astrana Health’s quarterly revenue was up 39.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.28 earnings per share. As a group, equities research analysts forecast that Astrana Health will post 1.31 earnings per share for the current year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.